StockData
Elicio Therapeutics, Inc. logo

Elicio Therapeutics, Inc. (ELTX) stock

ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.59+0.16 (+11.19%)

Close on Nov 18, 2026Market cap $41.79MP/E –Yield –

Elicio Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elicio Therapeutics's price to sales ratio was 4.6× on Jul 31, 2023, against 0.1× a year earlier. Over the last 3 years it ranged from 0.1× to 20.2×, with a median of 3.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 20234.6×+4.5
2022Dec 30, 20220.1×−3.1
2021Dec 31, 20213.2×–

More Elicio Therapeutics figures

See a number that looks wrong?